The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae
Abstract
From international tourists to war-displaced refugees, more people are on the move than ever before. This provides the opportunity for a variety of antimicrobial-resistant bacteria to be carried from one geographic location to another. The Enterobacteriaceae are among the most important causes of serious hospital-acquired and community-onset bacterial infections in humans, and resistance to antimicrobial agents in these bacteria has become an increasingly relevant problem. International travel and tourism are important modes for the acquisition and spread of antimicrobial-resistant Enterobacteriaceae, especially CTX-M-producing Escherichia coli. Infections with KPC-, VIM-, OXA-48- and NDM-producing Enterobacteriaceae in developed countries have been associated with visiting and being hospitalized in endemic areas such as the USA, Greece and Israel for KPCs, Greece for VIMs, Turkey for OXA-48, and the Indian subcontinent for NDMs. To combat the spread of antimicrobial-resistant Enterobacteriaceae, the French Healthcare Safety Advisory Committee recently issued national recommendations for screening and contact isolation precautions for patients transferred from, or hospitalized outside, France. For effective public and patient health interventions, it is important to understand the role of international travel in the spread of antimicrobial-resistant Enterobacteriaceae. We urgently need well-designed studies to evaluate the transmission potential and risks for colonization and infections due to multiresistant Enterobacteriaceae in travellers who have recently visited or have been hospitalized in endemic areas. The emergence of CTX-M-, KPC- and NDM-producing bacteria is a good example of the role that globalization plays in the rapid dissemination of new antibiotic resistance mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,519
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Global Spread of Carbapenemase-producing Enterobacteriaceae
Nordmann, P., Naas, T., & Poirel, L. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.110655 · Cited by 2,378
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,044
Self-citation(2022) · Singapore Medical Journal · doi:10.11622/smedj · Cited by 1,730
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Nordmann, P., Cuzon, G., & Naas, T. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70054-4 · Cited by 1,579
Walsh, T. R., Weeks, J., Livermore, D. M., & Toleman, M. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70059-7 · Cited by 1,250
Talbot, G. H., Bradley, J., Edwards, J. E., Gilbert, D., Scheld, M., & Bartlett, J. G. (2006) · Clinical Infectious Diseases · doi:10.1086/499819 · Cited by 1,104
Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae
Poirel, L., Héritier, C., Tolün, V., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.15-22.2004 · Cited by 997
Resistance in Gram-Negative Bacteria: Enterobacteriaceae
Paterson, D. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.013 · Cited by 874
Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community
Pitout, J. D. D., Nordmann, P., Laupland, K. B., & Poirel, L. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki166 · Cited by 790
Self-citationJacoby, G. A., & Munoz-Price, L. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041359 · Cited by 787
Journal of the Association of Physicians of India
(2023) · doi:10.5005/njem · Cited by 734
The emerging NDM carbapenemases
Nordmann, P., Poirel, L., Walsh, T. R., & Livermore, D. M. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.09.005 · Cited by 663
Extended-Spectrum B-Lactamase Genes of Escherichia coli in Chicken Meat and Humans, the Netherlands
Overdevest, I. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1707.110209 · Cited by 570
Resistance in gram-negative bacteria: Enterobacteriaceae
Paterson, D. L. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.05.238 · Cited by 535
Genetic Structures at the Origin of Acquisition of the β-Lactamase bla KPC Gene
Naas, T., Cuzon, G., Villegas, M.-V., Lartigue, M.-F., Quinn, J. P., & Nordmann, P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01451-07 · Cited by 515
The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter
Livermore, D. M., & Woodford, N. (2006) · Trends in Microbiology · doi:10.1016/j.tim.2006.07.008 · Cited by 510
Schwaber, M. J., Navon-Venezia, S., Kaye, K. S., Ben-Ami, R., Schwartz, D., & Carmeli, Y. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1257-1262.2006 · Cited by 416
Medical tourism: Assessing the evidence on treatment abroad
Lunt, N., & Carrera, P. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.01.017 · Cited by 392
Tängdén, T., Cars, O., Melhus, A., & Löwdin, E. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00220-10 · Cited by 372
Castanheira, M., Deshpande, L. M., Mathai, D., Bell, J. M., Jones, R. N., & Mendes, R. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01497-10 · Cited by 362
Karim, A., Poirel, L., Nagarajan, S., & Nordmann, P. (2001) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2001.tb10762.x · Cited by 359
Carbapenemases: Molecular Diversity and Clinical Consequences
Poirel, L., Pitout, J. D., & Nordmann, P. (2007) · Future Microbiology · doi:10.2217/17460913.2.5.501 · Cited by 309
Self-citationSpread of OXA-48-Encoding Plasmid in Turkey and Beyond
Carrër, A., Poirel, L., Yilmaz, M., Akan, O. A., Feriha, C., Cuzon, G., Matar, G., Honderlick, P., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01312-09 · Cited by 273
Walther-Rasmussen, J., & Høiby, N. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm226 · Cited by 271
Population Mobility, Globalization, and Antimicrobial Drug Resistance
MacPherson, D. W. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1511.090419 · Cited by 266
(1991) · FEMS Microbiology Letters · doi:10.1016/0378-1097(91)90112-n · Cited by 252
Batchelor, M., Hopkins, K., Threlfall, E. J., Clifton-Hadley, F. A., Stallwood, A. D., Davies, R. H., & Liebana, E. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1319-1322.2005 · Cited by 243
Emergence of Metallo-β-Lactamase NDM-1-Producing Multidrug-Resistant Escherichia coli in Australia
Poirel, L., Lagrutta, E., Taylor, P., Pham, J., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00878-10 · Cited by 243
Laupland, K. B., Church, D. L., Vidakovich, J., Mucenski, M., & Pitout, J. D. D. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.09.034 · Cited by 238
Self-citationHawser, S. P., Bouchillon, S. K., Hoban, D. J., Badal, R. E., Hsueh, P.-R., & Paterson, D. L. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00426-09 · Cited by 224
International Air Transport Association
Havel, B. F., & Sanchez, G. S. (2010) · Handbook of Transnational Economic Governance Regimes · doi:10.1163/ej.9789004163300.i-1081.664 · Cited by 202
The basic principles of migration health: Population mobility and gaps in disease prevalence
Gushulak, B. D., & MacPherson, D. W. (2006) · Emerging Themes in Epidemiology · doi:10.1186/1742-7622-3-3 · Cited by 201
Deshpande, P., Rodrigues, C. S., Shetty, A., Kapadia, F. N., Hedge, A., & Soman, R. N. (2010) · PubMed · Cited by 196
Naas, T., Nordmann, P., Vedel, G., & Poyart, C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4423-4424.2005 · Cited by 190
Perry, J. D., Naqvi, S. H., Mirza, I. A., Alizai, S. A., Hussain, A., Ghirardi, S., Orenga, S., Wilkinson, K., Woodford, N., Zhang, J., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr299 · Cited by 188
Country-to-Country Transfer of Patients and the Risk of Multi-Resistant Bacterial Infection
Rogers, B. A., Aminzadeh, Z., Hayashi, Y., & Paterson, D. L. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir273 · Cited by 183
Kennedy, K., & Collignon, P. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-1031-y · Cited by 178
Global spread of New Delhi metallo-β-lactamase 1
Hammerum, A. M., Toleman, M. A., Hansen, F., Kristensen, B., Lester, C. H., Walsh, T. R., & Fuursted, K. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70276-0 · Cited by 173
Samuelsen, O., Naseer, U., Tofteland, S., Skutlaberg, D. H., Onken, A., Hjetland, R., Sundsfjord, A., & Giske, C. G. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp018 · Cited by 171
Navon-Venezia, S., Leavitt, A., Schwaber, M. J., Rasheed, J. K., Srinivasan, A., Patel, J. B., & Carmeli, Y. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00987-08 · Cited by 170
Lascols, C., Hackel, M., Marshall, S. H., Hujer, A. M., Bouchillon, S., Badal, R., Hoban, D., & Bonomo, R. A. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr240 · Cited by 167
Metallo-β-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues
Cornaglia, G., Akova, M., Amicosante, G., Cantón, R., Cauda, R., Docquier, J., Edelstein, M. V., Frère, J., Füzi, M., Galleni, M., et al. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.10.008 · Cited by 151
Poirel, L., Ros, A., Carricajo, A., Berthelot, P., Pozzetto, B., Bernabeu, S., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01305-10 · Cited by 148
Peirano, G., Schreckenberger, P. C., & Pitout, J. D. D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01763-10 · Cited by 143
Self-citationExtended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers’ diarrhoea
Tham, J., Odenholt, I., Walder, M., Brolund, A., Ahl, J., & Melander, E. (2010) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365540903493715 · Cited by 109
Colonization of Returning Travelers With CTX‐M‐ProducingEscherichia coli
Peirano, G., Laupland, K. B., Gregson, D. B., & Pitout, J. D. D. (2011) · Journal of Travel Medicine · doi:10.1111/j.1708-8305.2011.00548.x · Cited by 103
Self-citationCuzon, G., Naas, T., Demachy, M. C., & Nordmann, P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01180-07 · Cited by 98
Kassis, N., Decré, D., Gautier, V., Burghoffer, B., Saliba, F., Mathieu, D., Samuel, D., Castaing, D., Petit, J., Dussaix, É., et al. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki389 · Cited by 89
Dhanji, H., Patel, R., Wall, R. A., Doumith, M., Patel, B., Hope, R., Livermore, D. M., & Woodford, N. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr041 · Cited by 85
Cuzon, G., Naas, T., Bogaerts, P., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00543-08 · Cited by 83
Intercontinental spread from Israel to Colombia of a KPC-3-producing Klebsiella pneumoniae strain
López, J. A., Correa, A., Navon‐Venezia, S., Correa, A., Torres, J. A., Briceno, D. F., Montealegre, M. C., Quinn, J. P., Carmeli, Y., & Villegas, M. V. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03209.x · Cited by 80
Emergence of New Delhi Metallo-β-Lactamase, Austria
Zarfel, G., Hoenigl, M., Leitner, E., Salzer, H. J. F., Feierl, G., Masoud, L., Valentin, T., Krause, R. G. E., & Grisold, A. J. (2010) · Emerging infectious diseases · doi:10.3201/eid1701.101331 · Cited by 79
al Naiemi, N., Zwart, B., Rijnsburger, M. C., Roosendaal, R., Debets-Ossenkopp, Y. J., Mulder, J. A., Fijen, C. A. P., Maten, W., Vandenbroucke‐Grauls, C. M. J. E., & Savelkoul, P. H. M. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00676-08 · Cited by 79
Introduction of OXA-48-producing Enterobacteriaceae to Israeli hospitals by medical tourism
Adler, A., Shklyar, M., Schwaber, M. J., Navon‐Venezia, S., Dhaher, Y., Edgar, R., Solter, E., Benenson, S., Masarwa, S., & Carmeli, Y. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr382 · Cited by 71
Pitout, J. D. D., Campbell, L., Church, D. L., Gregson, D. B., & Laupland, K. B. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00061-09 · Cited by 70
Self-citationCross-border transmission of OXA-48-producing Enterobacter cloacae from Morocco to France
Poirel, L., Ros, A., Carrër, A., Fortineau, N., Carricajo, A., Berthelot, P., & Nordmann, P. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr023 · Cited by 65
Colgan, R., Johnson, J. R., Kuskowski, M. A., & Gupta, K. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01200-07 · Cited by 64
Goldfarb, D. A., Harvey, S., Jessamine, K., Jessamine, P. G., Toye, B., & Desjardins, M. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00098-09 · Cited by 60
Freeman, J. T., McBride, S., Heffernan, H., Bathgate, T., Pope, C., & Ellis-Pegler, R. B. (2008) · Clinical Infectious Diseases · doi:10.1086/590941 · Cited by 57
Sirichote, P., Hasman, H., Pulsrikarn, C., Schønheyder, H. C., Samulioniené, J., Pornruangmong, S., Bangtrakulnonth, A., Aarestrup, F. M., & Hendriksen, R. S. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01792-09 · Cited by 50
Dortet, L., Radu, I., Gautier, V., Blot, F., Chachaty, É., & Arlet, G. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm455 · Cited by 46
Chan, H. L. E., Poon, L. M., Chan, S. G., & Teo, J. W. P. (2011) · PubMed · Cited by 45
Sannes, M. R., Belongia, E. A., Kieke, B. A., Smith, K., Kieke, A., Vandermause, M., Bender, J. B., Clabots, C., Winokur, P. L., & Johnson, J. R. (2008) · The Journal of Infectious Diseases · doi:10.1086/525530 · Cited by 35
Klebsiella pneumoniae producing KPC carbapenemase in a district general hospital in the UK
Virgincar, N., Iyer, S., Stacey, A., Maharjan, S., Pike, R., Perry, C., Wyeth, J., & Woodford, N. (2011) · Journal of Hospital Infection · doi:10.1016/j.jhin.2011.03.016 · Cited by 27
CTX-M Extended-spectrum β-Lactamases, Washington State
Kim, S., Hu, J., Gautom, R., Kim, J., Lee, B.-K., & Boyle, D. S. (2007) · Emerging infectious diseases · doi:10.3201/eid1303.060479 · Cited by 26
Poulou, A., Spanakis, N., Pournaras, S., Pitiriga, V. C., Ranellou, K., Markou, F., & Tsakris, A. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq363 · Cited by 24
Cited by
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
Munoz-Price, L. S., Poirel, L., Bonomo, R. A., Schwaber, M. J., Daikos, G. L., Cormican, M., Cornaglia, G., Garau, J., Gniadkowski, M., Hayden, M. K., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70190-7 · Cited by 1,627
Self-citationKlebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance
Navon-Venezia, S., Kondratyeva, K., & Carattoli, A. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux013 · Cited by 1,286
Colonization, Infection, and the Accessory Genome of Klebsiella pneumoniae
Martin, R. M., & Bachman, M. A. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00004 · Cited by 1,058
The global epidemiology of carbapenemase-producing Enterobacteriaceae
van Duin, D., & Doi, Y. (2017) · Virulence · doi:10.1080/21505594.2016.1222343 · Cited by 1,004
Mathers, A. J., Peirano, G., & Pitout, J. D. D. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00116-14 · Cited by 872
Self-citation
Metadata
- Authors
- van der Bij, A. K., & Pitout, J. D. D.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-06-07
- Volume
- 67
- Issue
- 9
- Pages
- 2090-2100
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2137912034
- Cited by
- 292
- References
- 70
- FWCI
- 12.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.